Skip to content
10-Q

Quarterly Report

CUBIST PHARMACEUTICALS INC

0001104659-14-033792

← back to feed
Filed
May 2, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 28, 2014 75.31M sh
Shares Diluted Q1 2014 · Mar 31, 2014 85.6M sh
Shares Diluted Q1 2014 · Mar 31, 2013 67.03M sh
Capex Q1 2014 · Mar 31, 2014 $1.88M
Capex Q1 2014 · Mar 31, 2013 $3.86M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $102.28M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $91.06M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $63.01M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $104.04M
Stockholders Equity Q1 2014 · Mar 31, 2014 $1.45B
Stockholders Equity Q1 2014 · Dec 31, 2013 $1.39B
Current Liabilities Q1 2014 · Mar 31, 2014 $285.36M
Current Liabilities Q1 2014 · Dec 31, 2013 $310.83M
Total Liabilities Q1 2014 · Mar 31, 2014 $1.69B
Total Liabilities Q1 2014 · Dec 31, 2013 $1.75B
Current Assets Q1 2014 · Mar 31, 2014 $868.26M
Current Assets Q1 2014 · Dec 31, 2013 $869.77M
Total Assets Q1 2014 · Mar 31, 2014 $3.13B
Total Assets Q1 2014 · Dec 31, 2013 $3.15B
Eps Diluted Q1 2014 · Mar 31, 2014 $0.30
Eps Diluted Q1 2014 · Mar 31, 2013 $0.09
Eps Basic Q1 2014 · Mar 31, 2014 $0.32
Eps Basic Q1 2014 · Mar 31, 2013 $0.09
Sga Expense Q1 2014 · Mar 31, 2014 $69.66M
Sga Expense Q1 2014 · Mar 31, 2013 $48.2M
Rd Expense Q1 2014 · Mar 31, 2014 $120.6M
Rd Expense Q1 2014 · Mar 31, 2013 $114.21M
Operating Income Q1 2014 · Mar 31, 2014 $28.31M
Operating Income Q1 2014 · Mar 31, 2013 $9.79M
Cost Of Revenue Q1 2014 · Mar 31, 2014 $73.54M
Cost Of Revenue Q1 2014 · Mar 31, 2013 $55.68M
Revenue Q1 2014 · Mar 31, 2014 $261.23M
Revenue Q1 2014 · Mar 31, 2013 $229.93M